TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers.
TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers.
Recruiting · NCT07009184 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers. | HER2 Positive Solid Tumor | Recruiting | Early phase 1 | 2026-08-18 | NCT07009184 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Radboud University Medical Center | 216 |
| Tagworks Pharmaceuticals BV | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Radboud University Medical Center | Nijmegen | Netherlands | 1 |